Short-Term Daily Intake of Polydextrose Fiber Does Not Shorten Intestinal Transit Time in Constipated Adults: A Randomized Controlled Trial
Authors:
- Peter I. DuncanPDPeter I. Duncan
- Catherine F. Enters-WeijnenCECatherine F. Enters-Weijnen
- Nashmil EmamiNENashmil Emami
- Peter McLeanPMPeter McLean
- Tiago NunesTNTiago Nunes
- Maurice BeaumontMBMaurice Beaumont
- Rafael CrabbeRCRafael Crabbe
- Kevin WhelanKWKevin Whelan
- S. Mark ScottSSS. Mark Scott
- Niek J. DeWitNDNiek J. DeWit
- Teunis WeitsTWTeunis Weits
- Gabriela BergonzelliGBGabriela Bergonzelli
Open Access
Abstract
Chronic constipation (CC) remains a common gastrointestinal (GI) disorder that conveys a substantial healthcare burden. Expert guidelines recommend increasing fiber intake, yet the clinical evidence to support this needs strengthening for specific fibers. The aim was to evaluate changes in intestinal transit time and GI symptoms in CC patients who consumed polydextrose. In a randomized, double-blind, placebo-controlled trial, 128 adults with CC received 8 g or 12 g polydextrose, or placebo, daily for 4 weeks. Transit time, as primary outcome, was assessed by radiopaque marker distribution after 2-weeks intervention. Bowel habits, GI symptoms and quality of life (QOL) were assessed by questionnaire, including the Patient-Assessment of Constipation (PAC) Symptoms (SYM), and PAC-QOL. Following 2-weeks intervention, no reduction was seen in transit time in any group and following 2- or 4-weeks intervention, no improvements were seen in stool frequency or consistency in any group. After 2-weeks intervention with 8 g/day polydextrose an improvement was seen in the PAC-SYM rectal score (p = 0.041). After 4-weeks intervention both rectal (p = 0.049) and stool (p = 0.029) scores improved while improvement in the QOL satisfaction score did not reach significance (p = 0.071). Overall, the results suggest that 2-weeks consumption of 8 or 12 g/day polydextrose does not significantly improve physiological measures of gut function in CC adults. Longer term consumption may improve clinical measures, but further studies will be required to substantiate this.Keywords
This publication has 69 references indexed in Scilit:
- American Gastroenterological Association Medical Position Statement on ConstipationGastroenterology, 2013
- Epidemiology of functional constipation and comparison with constipation-predominant irritable bowel syndrome: the Systematic Investigation of Gastrointestinal Diseases in China (SILC)Alimentary Pharmacology & Therapeutics, 2011
- Dose-response effect ofBifidobacterium lactisHN019 on whole gut transit time and functional gastrointestinal symptoms in adultsScandinavian Journal of Gastroenterology, 2011
- Diagnosis and treatment of chronic constipation - a European perspectiveNeurogastroenterology & Motility, 2011
- Systematic review: the effects of fibre in the management of chronic idiopathic constipationAlimentary Pharmacology & Therapeutics, 2011
- Systematic review: impact of constipation on quality of life in adults and childrenAlimentary Pharmacology & Therapeutics, 2010
- A Review of the Literature on Gender and Age Differences in the Prevalence and Characteristics of Constipation in North AmericaJournal of Pain and Symptom Management, 2009
- Definition and epidemiology of functional gastrointestinal disordersBest Practice & Research Clinical Gastroenterology, 2004
- Stool Form Scale as a Useful Guide to Intestinal Transit TimeScandinavian Journal of Gastroenterology, 1997
- Gastrointestinal and Colonic Segmental Transit Time Evaluated by a Single Abdominal X-ray in Healthy Subjects and Constipated PatientsScandinavian Journal of Gastroenterology, 1988